Citius Pharmaceuticals (CTXR) Stock Surges to $0.75 Amid Milestone Announcements, Eyes $0.85

Citius Pharmaceuticals (CTXR) has shown significant movement in the stock market this week. The stock, which was heavier in premarket trading, saw a notable increase in volume, approaching 400,000 shares. It broke above the $0.72 level and reached $0.75 after the market opened. This surge follows the company's announcement detailing near-term milestones for its late-stage candidates. Investors are watching for a potential continuation to $0.85 and possibly $1.00, with key levels to watch at $0.69/$0.70. The premarket news has been a driving factor in the stock's performance.